Vabysmo

Vabysmo is a medicine used to treat adults with: - the ‘wet’ form of age-related macular degeneration (AMD), a disease that affects the central part of the retina (called the macula) at the back of the eye. The wet form of AMD is caused by abnormal growth of blood vessels beneath the retina which may leak fluid and blood and cause swelling; - impaired vision due to macular oedema (swelling) caused by diabetes; - impaired vision due to a swelling of the macula caused by retinal vein occlusion (RVO, a blockage of the blood flow in a vein of the retina). The macula provides central vision that is needed to see details for everyday tasks such as driving, reading and recognising faces. The diseases cause the gradual loss of the central part of a person’s vision. Vabysmo contains the active substance faricimab.